International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 3 , Pages 677-682 , 1 November 2009

Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study

  • Achilles J. Fakiris, M.D.

      Affiliations

    • Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN
    • Corresponding Author InformationReprint requests to: Achilles J. Fakiris, MD, Department of Radiation Oncology, Indiana University School of Medicine, 535 Barnhill Dr., RT 041, Indianapolis, IN 46202. Tel: (317) 274-2524; Fax: (317) 274-2486
    • ,
  • Ronald C. McGarry, M.D., Ph.D.

      Affiliations

    • Department of Radiation Medicine, University of Kentucky, Lexington, KY
    • ,
  • Constantin T. Yiannoutsos, Ph.D.

      Affiliations

    • Division of Biostatistics, Indiana University School of Medicine, Indianapolis, IN
    • ,
  • Lech Papiez, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX
    • ,
  • Mark Williams, M.D.

      Affiliations

    • Division of Pulmonology, Indiana University School of Medicine, Indianapolis, IN
    • ,
  • Mark A. Henderson, M.D.

      Affiliations

    • Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN
    • ,
  • Robert Timmerman, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX

Received 4 September 2008 ,Revised 24 November 2008 ,Accepted 27 November 2008.

References 

  1. Mountain CF. A new international staging system for lung cancer. Chest. 1986;89:225S–233S
  2. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 1988;96:440–447
  3. Dominioni L, Imperatori A, Rovera F, et al. Stage I nonsmall cell lung carcinoma: Analysis of survival and implications for screening. Cancer. 2000;89:2334–2344
  4. Coy P, Kennelly GM. The role of curative radiotherapy in the treatment of lung cancer. Cancer. 1980;45:698–702
  5. Armstrong JG, Minsky BD. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev. 1989;16:247–255
  6. Haffty BG, Goldberg NB, Gerstley J, et al. Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1988;15:69–73
  7. Kaskowitz L, Graham MV, Emami B, et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1993;27:517–523
  8. Dosoretz DE, Katin MJ, Blitzer PH, et al. Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy. Semin Radiat Oncol. 1996;6:98–104
  9. Dosoretz DE, Katin MJ, Blitzer PH, et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys. 1992;24:3–9
  10. Sibley GS, Jamieson TA, Marks LB, et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys. 1998;40:149–154
  11. Blomgren H, Lax I, Naslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 1995;34:861–870
  12. Onishi H, Kuriyama K, Komiyama T, et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: Patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer. 2004;45:45–55
  13. Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys. 2001;51:666–670
  14. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a Phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427–1431
  15. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45:787–795
  16. Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer–mature results for medically inoperable patients. Lung Cancer. 2006;51:97–103
  17. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer. 2005;48:107–114
  18. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol. 2006;45:796–801
  19. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003;124:1946–1955
  20. McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early–stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys. 2005;63:1010–1015
  21. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–4839
  22. Papiez L, Timmerman R, DesRosiers C, et al. Extracranial stereotactic radioablation: Physical principles. Acta Oncol. 2003;42:882–894
  23. McGarry RC, Song G, des Rosiers P, et al. Observation-only management of early stage, medically inoperable lung cancer: Poor outcome. Chest. 2002;121:1155–1158
  24. Raz DJ, Zell JA, Ou SH, et al. Natural history of stage I non-small cell lung cancer: Implications for early detection. Chest. 2007;132:193–199
  25. Shennib H, Bogart J, Herndon JE, et al. Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: The Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg. 2005;129:813–818
  26. Henderson M, McGarry R, Yiannoutsos C, et al. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;72:404–409
  27. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101:1623–1631

 Accepted for oral presentation at American Society of Therapeutic Radiation Oncology 2008.

 Conflict of interest: none.

PII: S0360-3016(08)03850-9

doi: 10.1016/j.ijrobp.2008.11.042

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 3 , Pages 677-682 , 1 November 2009

Article Tools

* Image Usage & Resolution